Reptile Rescue & Relocation

03/10/2026

A protein from a specific spider venom

https://www.facebook.com/share/1L1L1AMkH2/

Dravet syndrome is one of the most severe forms of childhood epilepsy. Seizures begin in
infancy, resist most treatments, and can be life-threatening. Parents have had very few options.
Now an experimental drug called zorevunersen is showing extraordinary results. In clinical trials,
it reduced seizures by up to 91% while also improving quality of life for many of the children.
The drug works by targeting the underlying genetic cause of the condition, not just managing
symptoms.
For families who have spent years watching their children suffer through dozens of seizures a
day, this could be genuinely life-changing.
Source: ScienceDaily, March 2026
Shared for informational purposes only. Consult a medical professional for health advice.

03/09/2026

https://www.facebook.com/share/p/14VDbGfUdBN/

Neuroscientists and hematologists at the Walter and Eliza Hall Institute of Medical Research in Melbourne have identified a platelet-secreted protein — Platelet Factor 4 variant PF4-ΔC — that is present at significantly lower concentrations in glioblastoma patients than healthy controls, and that in experimental models powerfully suppresses glioblastoma growth by inhibiting the CXCR3 receptor pathway through which GBM cells drive angiogenesis and immune evasion — achieving 91% tumor growth inhibition in orthotopic mouse models and 78% reduction in tumor volume in a 20-patient compassionate use trial of recurrent GBM. A protein circulating in your blood naturally suppresses brain cancer. In GBM patients, it's depleted by the tumor itself. 🧠
Glioblastoma's survival of the immune response depends on active suppression of the natural anti-tumor mechanisms that would otherwise contain it. PF4-ΔC is normally secreted by platelets during coagulation and wound response — but GBM tumor cells express metalloproteinase enzymes that selectively cleave and inactivate the platelet PF4-ΔC in the tumor microenvironment, removing its anti-angiogenic and immune-activating effects from the tissue surrounding the tumor. The tumor effectively disarms the very platelet protein that would suppress its growth. Restoring pharmacological PF4-ΔC concentrations at the tumor site reverses this immune evasion and anti-angiogenic suppression simultaneously.
Glioblastoma kills 95% of patients within 2 years of diagnosis despite surgery, radiation, and chemotherapy — it is medicine's most treatment-resistant solid tumor. The median survival of 15 months has barely moved in 20 years despite hundreds of clinical trials of targeted therapies. PF4-ΔC addresses a mechanism — active tumor suppression of an endogenous anti-tumor factor — that no previous therapy has targeted, representing a completely orthogonal approach to all existing GBM treatment.
Walter and Eliza Hall Institute is conducting a Phase II trial with Roche. The protein your own platelets make may be the key to treating the brain cancer that treatment cannot currently touch.
Source: Walter and Eliza Hall Institute Melbourne / Roche, Nature Cancer 2025

03/08/2026

https://www.facebook.com/share/p/1CbA9n5873/

Scientists have captured the most detailed image of a human cell ever recorded, revealing structures and interactions never seen before. The breakthrough offers a deeper understanding of how life operates at the microscopic level.

Using advanced cryo electron microscopy and high resolution digital imaging systems, researchers froze cells at extremely low temperatures to preserve their natural structure. This allowed them to scan the cell in ultra fine detail, mapping proteins, membranes, and organelles with remarkable clarity. The resulting image shows complex networks that control metabolism, communication, and energy production.

This discovery highlights how science and technology are transforming cellular research. By combining nanotechnology, imaging innovation, and computational analysis, scientists can observe biological processes as they occur. Such insights may help researchers better understand diseases, drug interactions, and cellular aging.

As imaging tools continue to evolve, scientists are uncovering layers of complexity within the human body. Each new detail helps refine medical research and biotechnology. The future of science may depend on exploring life at scales smaller than ever imagined.

03/06/2026

New Wildlife and Research Center in development!

03/04/2026

https://www.facebook.com/share/1HogR9yexA/

Researchers at Wake Forest have developed CAR-macrophages (CARMA), engineered to infiltrate solid tumors, cross the blood-brain barrier, and coordinate the immune response.

Early preclinical studies suggest this approach could transform treatment for brain metastases.

Read more: https://bit.ly/4r6qUWr

03/04/2026

Development of methods to treat mental health without SSRI or SNRI

Overall, elucidating the intricate mechanisms of arachnid venom peptides in penetrating lipid bilayer membranes not only enhances our understanding of venom biology, but also holds immense promise for the development of novel therapeutic drugs and bioinsecticides.

https://www.frontiersin.org/journals/arachnid-science/articles/10.3389/frchs.2024.1490313/full

https://www.facebook.com/share/p/1B7oXMbMy1/

Arachnid venom peptides receive increasing attention from researchers for possible applications as human therapeutics, as bioinsecticides in agriculture or f...

03/04/2026

Conclusion
The combination of Vortioxetine and ESK-NS may be a valuable alternative to the standard-of-care SSRI/SNRI plus ESK-NS in TRD patients, particularly regarding the reduction of emotional blunting and potentially a better safety and tolerability profile. Further randomized controlled trials with larger sample sizes and prospective designs are needed to confirm these findings

... but your computer or network may be sending automated queries. To protect our users, we can't process your request right now.

03/04/2026

Black widow spider venom-induced release of neurotransmitters: Mammalian synaptosomes are stimulated by a unique venom component

https://www.facebook.com/share/p/1SGWtjYv3K/

03/04/2026

https://www.facebook.com/share/p/1G6RX4PXi1/

A new class of peptides, mambalgins, is isolated from the African snake the black mamba, which can abolish pain through inhibition of particular subtypes of acid-sensing ion channels expressed either in central or peripheral neurons.

09/02/2024

08/25/2024

Check out Snakebitemaster’s post.